pharma · Infertility in women undergoing assisted reproductive technologies (ART) · Intermediate risk, non-muscle invasive bladder cancer
Ferring Pharmaceuticals
Ferring Pharmaceuticals is a pharma organization headquartered in Mumbai, IN. Primary therapeutic focus areas include Infertility in women undergoing assisted reproductive technologies (ART), Intermediate risk, non-muscl
Company details
- Status
- Public
- HQ
- -, St-Prex, 1162, CH, Mumbai
- Founded
- 1950
- Employees
- 6,228
- Programs
- 13
- Drugs
- 23
- Patents
- 0
TRI-001-01
Phase 2 · small molecule · Patients with Chronic Limb Threatening Ischemia (CLTI) due to Peripheral Arterial Disease (PAD)
TRI-001-01 for Patients with Chronic Limb Threatening Ischemia (CLTI) due to Peripheral Arterial Disease (PAD) is a Phase 2 program (small_molecule) at Ferring Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code TRI-001-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ferring Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Patients with Chronic Limb Threatening Ischemia (CLTI) due to Peripheral Arterial Disease (PAD)
- Status
- active
- Trials
- 1